Esperion Therapeutics, Inc. Share Price
ESPR
$2.42
+$0.10 (4.54%) Last updated on 04 Sep, 2025 | 01:29 ISTEsperion Therapeutics, Inc. Stock Performance
Open $2.29 | Prev. Close $2.31 | Circuit Range N/A |
Day Range $2.28 - $2.44 | Year Range $0.69 - $3.94 | Volume 2,60,042 |
Average Traded $2.36 |
Esperion Therapeutics, Inc. Share Price Chart
$2.42
About Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease who require additional lowering of LDL-C. Its products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. It has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.
Esperion Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
03-Sep-25 | $2.29 | $2.42 | +4.76% |
02-Sep-25 | $2.22 | $2.31 | +4.05% |
29-Aug-25 | $2.23 | $2.22 | +0.91% |
28-Aug-25 | $2.18 | $2.20 | +0.69% |
27-Aug-25 | $2.18 | $2.19 | -0.23% |
26-Aug-25 | $2.14 | $2.19 | +2.34% |
25-Aug-25 | $2.16 | $2.14 | -1.38% |
FAQs on Esperion Therapeutics, Inc. Share Price
Can I buy Esperion Therapeutics, Inc. shares in India?
What is the share price of Esperion Therapeutics, Inc.?
What is the 5 year returns of Esperion Therapeutics, Inc.?
What are the high & low stock price of Esperion Therapeutics, Inc. today?
What is the 52-week high and low of Esperion Therapeutics, Inc. stock?